Riskpilot← Back to searchSign inGet full accessPrimediosys AB
ABActiveOrg 5564801925Artemisgatan 37 Lgh 1203General medical practice activities · NACE 8621Est. 19941-4 employees
Revenue 2025
SEK 1,8M
+9% vs 2024
EBITDA margin
34.2%
+82% vs 2024
Equity ratio
37.6%
Financial strength
Net profit 2025
SEK 306K
-18% vs 2024
| Revenue | SEK 1,8M | +9% |
| EBITDA | SEK 618K | +82% |
| Net profit | SEK 306K | -18% |
| Total assets | SEK 1,3M | -8% |
| Equity | SEK 484K | -19% |
| Employees | — | — |
Legal name
Primediosys AB
Org number
5564801925
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 februari 1994
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsult-, undervisningsverksamhet, import och försäljning inom data och medicinområdet. Bolaget skall även ägna sig åt handel med fastigheter och bostadsrätter samt äga och förvalta bostadsrätter.
Address
Artemisgatan 37 Lgh 1203
Phone
+4686986979
Email
faktura@primedio.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 322 | 1 850 | 2 208 | 1 653 | 1 807 |
| Staff expenses | −1 160 | −906 | −943 | −1 044 | — |
| EBITDA | 704 | 387 | 862 | 340 | 618 |
| Depreciation & amort. | −86 | −56 | −27 | −27 | −27 |
| EBIT | 617 | 331 | 836 | 314 | 591 |
| Net financials | −6 | −7 | 4 | 5 | 83 |
| Profit before tax | 344 | 324 | 673 | 473 | 388 |
| Tax | −72 | −69 | −141 | −100 | −82 |
| Net profit | 272 | 255 | 531 | 373 | 306 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 286 | 977 | 1 545 | 1 394 | 1 288 |
| Equity | 466 | 381 | 711 | 598 | 484 |
| Long-term debt | 172 | 102 | 111 | 47 | 47 |
| Short-term debt | 410 | 255 | 347 | 552 | 511 |
| Total debt | 581 | 358 | 458 | 599 | 558 |
EBITDA margin
34.2%
This company
15.8%
Market median
+116% vs market
20212025
Equity ratio
37.6%
This company
38.2%
Market median
+2% vs market
20212025
Return on equity
63.2%
This company
18.4%
Market median
+243% vs market
20212025
Net profit margin
16.9%
This company
8.1%
Market median
+109% vs market
20212025
Asset turnover
1.40×
This company
1.12×
Market median
+25% vs market
20212025
Debt / equity
1.66×
This company
0.62×
Market median
-168% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
PE | Audit | 2020 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2024 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2024 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Primediosys AB 
Såg & Spade Blidö ABBoard members of Primediosys AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Petter Erik Gustafsson | Audit | 0 companies |
| Nils Birger Ragnarson | Board of Directors | 0 companies |
| Eeva-Leena Ragnarson-Nõu | Deputy Board Member | 0 companies |
| Maj Iréne Almqvist | Deputy Board Member | 0 companies |
| Odysseas Ion Nils Ragnarson | Deputy Board Member | 0 companies |